© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
January 09, 2018
Evidence-Based Diabetes Management
January 03, 2018
December 26, 2017
December 19, 2017
An interview with one of the authors of a large observational study that has seen findings consistent with recent cardiovascular outcomes trials in SGLT2 inhibitors.
December 18, 2017
Evidence is more robust on kidney function but not sufficient to make drug decisions, one expert said. A whole separate trial, called CREDENCE, is examining renal function in patients taking canagliflozin.
December 14, 2017
A chief medical officer for a major payer outlines the challenges making sure that certain high-cost therapies are directed to the patients who need them.
From the Editor in Chief
December 13, 2017
The payment reform movement has changed the thinking about what can be done for patients with diabetes and heart failure, for the good of patients.
December 12, 2017
CMS can take steps to raise awareness, including a specific quality measure, to ensure that testing occurs prior to nontraumatic amputation.